Cardiff Oncology shares plunge after Q2 earnings miss
CAMPBELL, Calif. - Semler Scientific, Inc. (NASDAQ: SMLR), known for its significant Bitcoin holdings and healthcare technology, announced the appointment of Natalie Brunell to its board of directors today. The company, which is recognized as the fourth largest U.S. public company holding Bitcoin, underscored the move as a step to bolster its Bitcoin treasury strategy. According to InvestingPro data, the company’s stock has shown remarkable momentum, delivering a 77.66% return over the past year, though current analysis suggests the stock may be trading above its Fair Value.
Brunell, a prominent figure in the Bitcoin community, brings a wealth of experience as a journalist, educator, and advocate for the digital currency. Her background includes hosting a top-rated Bitcoin podcast, ’Coin Stories,’ and a tenure as an award-winning TV journalist. She also served as an adjunct professor at the University of Southern California and holds a Master’s degree in Journalism from Northwestern University.
Chairman Eric Semler expressed enthusiasm about Brunell’s addition to the board, citing her deep understanding of Bitcoin and its potential to transform assets. Brunell reciprocated the sentiment, stating her eagerness to contribute to the growth and success of Semler Scientific’s Bitcoin strategy.
Semler Scientific’s decision to adopt Bitcoin as its primary treasury reserve asset dates back to May 2024, making it the second U.S. publicly traded company to do so. The company has been using proceeds from equity and debt financings, along with cash flows from operations, to strategically accumulate Bitcoin.
Apart from its Bitcoin endeavors, Semler Scientific is also pioneering in the healthcare sector with its patented QuantaFlo® product. This FDA-cleared, rapid point-of-care test measures arterial blood flow and aids in diagnosing cardiovascular diseases such as peripheral arterial disease (PAD). The company is currently seeking new 510(k) clearance for expanded indications for QuantaFlo, which is used by healthcare providers to evaluate the risk of mortality and major adverse cardiovascular events (MACE) in patients. InvestingPro analysis reveals impressive gross profit margins of 90.96%, though analysts expect net income to decline this year. Discover 10+ additional exclusive insights and detailed financial analysis in the comprehensive Pro Research Report, available with an InvestingPro subscription.
The information in this article is based on a press release statement from Semler Scientific, Inc. For deeper insights into Semler Scientific’s financial health, valuation metrics, and growth potential, visit InvestingPro, where you’ll find expert analysis and real-time data to inform your investment decisions.
In other recent news, Semler Scientific reported a net loss of $64.7 million for the first quarter of 2025, with earnings per share at -$6.74. The company’s revenue saw a significant decline of 44% year-over-year, totaling $8.8 million. Despite these financial challenges, Semler Scientific’s stock experienced a 5.34% increase in aftermarket trading. The company has been focusing on expanding its Bitcoin treasury, with plans to use cash generated from its healthcare business to purchase more Bitcoin. Semler Scientific has already acquired 3,808 Bitcoins, valued at approximately $400 million, making it one of the largest corporate Bitcoin holders in the U.S. The company is also navigating pressures from changes in CMS payments and reduced PAD testing volumes, which have impacted operations. Analysts have noted the company’s ambitious Bitcoin acquisition goals and its strategic efforts in the cardiovascular market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.